Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Syndax Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.

Get SNDX alerts

About Nicholas Botwood

Nicholas Botwood has spoken on 2 earnings calls across 1 company, most recently for Syndax Pharmaceuticals Inc on August 4, 2026. Syndax Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Syndax Pharmaceuticals Inc includes Michael A. Metzger (CEO and Board Member), Michael Metzger (CEO), Aaron A. Ondrey (CFO and Chief Accounting Officer) and 7 others.

Nicholas Botwood on recent calls

“Turning to slide nine, I'd like to highlight the progress we've made advancing our scientific leadership in men and inhibition with a strong presence in medical meetings and two landmark publications.”
Other, Syndax Pharmaceuticals Inc Q2 FY2026 Earnings Call ·
“It's a pleasure to be on the call today to discuss the important milestones ahead and update on our pipeline.”
Other, Syndax Pharmaceuticals Inc Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Syndax Pharmaceuticals Inc

Recent activity